Today: 10 June 2026
S&P 500 hits record, chip stocks jump — jobs report and Trump tariff case set up next market move

S&P 500 hits record, chip stocks jump — jobs report and Trump tariff case set up next market move

NEW YORK, Jan 9, 2026, 18:38 EST

The S&P 500 closed at a record on Friday as Broadcom and other chip stocks kept Wall Street climbing after a softer-than-expected U.S. jobs report. The index rose 0.65% to 6,966.28, while the Nasdaq gained 0.82% to 23,671.35 and the Dow added 0.48% to 49,504.07; the PHLX semiconductor index, which tracks major chipmakers, jumped 2.7% to a record. “On the overall AI theme, investors are getting granular,” said Zachary Hill at Horizon Investments, as Lam Research surged after Mizuho lifted its price target and Vistra rallied on a power deal with Meta. Reuters

The labor data mattered because it set the tone for the next Fed meeting and for how traders price rate cuts in 2026. Nonfarm payrolls — jobs outside farming — rose by 50,000 in December, below economists’ forecast of 60,000, after a downwardly revised 56,000 in November. The unemployment rate dipped to 4.4% and wages rose 3.8% from a year earlier, and “all roads lead to the unemployment rate … it should douse the Fed’s recent urgency,” Fitch Ratings’ Olu Sonola said. Reuters

Interest-rate futures now lean toward the Fed staying put for months, after the central bank cut its benchmark overnight rate by three-quarters of a percentage point last year. Traders see a 44% chance of a cut by April and have shifted toward June as a more likely point for the next move, Reuters reported. Richmond Fed President Thomas Barkin told reporters companies are in a “low-hire” environment, pointing to uncertainty and higher productivity. Reuters

Bond traders braced for volatility on Friday, watching the jobs report and the Supreme Court’s looming decision on Trump’s tariffs.

In markets after the data, the dollar index rose 0.26% to 99.13, while the two-year Treasury yield — which tends to track Fed expectations — climbed five basis points to 3.538% as the 10-year yield slipped to 4.171%. “We are back to normal in terms of economic reporting,” Tim Ghriskey at Ingalls & Snyder said, after a long federal government shutdown delayed U.S. statistics. The Supreme Court is expected to issue its next rulings on Jan. 14, Reuters reported. Reuters

Housing-linked stocks also ran higher after Trump ordered $200 billion in purchases of mortgage bonds — securities backed by home loans — in a bid to lower mortgage rates and monthly payments, according to his Truth Social post. FHFA Director Bill Pulte said Fannie Mae and Freddie Mac will execute the buying, while TD Cowen said it could narrow the gap between 30-year mortgage rates and 10-year Treasury yields. “Every little bit will help push mortgage yields lower, but this might be self-defeating,” said Brian Jacobsen, chief economic strategist at Annex Wealth Management. Reuters

The tariff case is the other live wire. The Supreme Court is weighing whether Trump can use the International Emergency Economic Powers Act — a law meant for emergencies — to impose tariffs without Congress. Some investors see upside if tariffs get rolled back and importers receive $150 billion to $200 billion in refunds, but KEY Advisors’ Eddie Ghabour warned that kind of fiscal hit would “suck liquidity out of the system,” while JPMorgan estimated annualized tariff revenue could fall to about $250 billion from roughly $350 billion if the administration pivots to other legal routes. Reuters

The next test is corporate earnings and inflation data. JPMorgan is due Tuesday as banks kick off fourth-quarter results, and December CPI inflation could shape the Fed debate. Analysts expect S&P 500 profits to have risen 13% in 2025 and to grow more than 15% in 2026, according to LSEG IBES, even as Michael Arone at State Street warned the market “seems a little too quiet” given events ahead. Reuters

But the downside scenario is plain: inflation stays sticky and the Fed stays on hold longer than markets want. Atlanta Fed President Raphael Bostic said “inflation is still too high” and urged policy makers to stay laser-focused on prices, even as he described a job market in low-hire, no-fire mode. He also noted housing affordability problems go beyond financing — a reminder that cheaper mortgages alone may not fix a supply squeeze. Reuters

Stock Market Today

  • Copart (CPRT) Share Price Slump Raises Reassessment Questions Amid Undervaluation
    June 10, 2026, 8:50 AM EDT. Copart's share price has declined 37.7% over the past year, prompting investors to reassess its value. Recent trading closed at $31.31, a 1.5% rise over seven days but down 17.1% year to date. A Discounted Cash Flow (DCF) analysis estimates Copart's intrinsic value at $38.93, suggesting the stock is undervalued by approximately 19.6%. The DCF model, focusing on future free cash flow projections, indicates potential upside if cash flow assumptions hold. Copart trades at a Price-to-Earnings (P/E) ratio of 18.66, reflecting investor expectations on growth and risk. The prolonged multi-year price slump, coupled with evolving market perceptions in vehicle auction and salvage sectors, is driving fresh investor scrutiny on Copart's risk and growth potential.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Previous Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next
Next Story

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

Go toTop